Trials of autologous bone marrow stem cells for heart disease

The report by Nowbar and colleagues (doi:10.1136/bmj.g2688) on the relation between the number of discrepancies observed in clinical trials of autologous bone marrow stem cells for ischaemic heart disease and ejection fraction includes shambolic and poorly conducted research that reflects poorly ...